Calendar Prostatype Genomics AB

Equities

PROGEN

SE0014684569

Market Closed - Nasdaq Stockholm 11:29:33 2024-04-26 am EDT 5-day change 1st Jan Change
0.0364 SEK -3.70% Intraday chart for Prostatype Genomics AB -17.65% -61.68%

Chart calendar Prostatype Genomics AB

827e4d3736b99484d9b4ec67d526da75.fxyxoy9aXdjt00RBwMM5vY5pEE-8K93qKtOKTf6sZHA.Pinn62AvAonenHwWrJVy9vklaB2OGe2QGoGnCM_LACJHfvfHXgMsntmYcA~d7fc3e984a8c281a09621e53a6844d3c

Upcoming events on Prostatype Genomics AB

2024-05-22 Q1 2024 Earnings Release (Projected)
2024-08-14 Q2 2024 Earnings Release (Projected)
2024-11-07 Q3 2024 Earnings Release (Projected)
2025-02-12 Q4 2024 Earnings Release (Projected)

Past events on Prostatype Genomics AB

2024-02-15 02:00 am Q4 2023 Earnings Release
2023-11-10 02:00 am Q3 2023 Earnings Release
2023-08-17 02:00 am Q2 2023 Earnings Release
2023-05-31 Annual General Meeting
2023-05-31 02:00 am Q1 2023 Earnings Release
2023-03-30 12:00 am Redeye Future of Healthcare Event
2023-02-15 FY 2022 Earnings Release
2022-11-10 02:00 am Q3 2022 Earnings Release
2022-08-17 Interim 2022 Earnings Release
2022-06-01 Annual General Meeting
2022-05-12 02:00 am Q1 2022 Earnings Release
2022-02-24 02:00 am FY 2021 Earnings Release
2021-11-17 Q3 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2021 2022
Net sales
Released
Forecast
Spread
0,00


0,00


EBITDA
Released
Forecast
Spread
0,00


0,00


EBIT
Released
Forecast
Spread
0,00


0,00


Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
0,00


-29,1


Net income
Million SEK
Released
Forecast
Spread
-15,6


-29,1


EPS
SEK
Released
Forecast
Spread
-1,04


0,00


Announcement Date24/02/2217/02/23

Quarterly results

Fiscal PeriodDecember 2023 Q2
Net sales
Million SEK
Released
Forecast
Spread
0,06
0,80
-93.04%
EBITDA
Million SEK
Released
Forecast
Spread
-9,59
-7,00
-36.96%
EBIT
Million SEK
Released
Forecast
Spread
-10,1
-8,00
-25.71%
EPS
SEK
Released
Forecast
Spread
-0,08
-1,00
92%
Announcement Date17/08/23

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PROGEN Stock
  4. Calendar Prostatype Genomics AB